Needham & Company LLC Boosts Plexus (NASDAQ:PLXS) Price Target to $206.00

Plexus (NASDAQ:PLXS) had its price target lifted by Needham & Company LLC from $165.00 to $206.00 in a research note issued on Friday,Benzinga reports. The firm currently has a “buy” rating on the technology company’s stock. Needham & Company LLC’s target price would indicate a potential upside of 4.25% from the stock’s current price.

PLXS has been the subject of several other reports. Weiss Ratings reissued a “hold (c+)” rating on shares of Plexus in a report on Thursday, January 22nd. Wall Street Zen downgraded Plexus from a “buy” rating to a “hold” rating in a report on Saturday, November 22nd. Stifel Nicolaus set a $150.00 target price on shares of Plexus in a report on Friday, October 24th. Williams Trading set a $195.00 price target on shares of Plexus in a research report on Wednesday. Finally, Sidoti downgraded shares of Plexus from a “buy” rating to a “neutral” rating and set a $150.00 price objective on the stock. in a research report on Friday, October 24th. Two investment analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company. According to data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and an average target price of $179.20.

Plexus Price Performance

Shares of NASDAQ PLXS opened at $197.60 on Friday. The stock’s 50-day simple moving average is $158.75 and its 200-day simple moving average is $145.40. The firm has a market capitalization of $5.29 billion, a PE ratio of 30.73 and a beta of 0.81. Plexus has a fifty-two week low of $103.43 and a fifty-two week high of $198.76. The company has a debt-to-equity ratio of 0.06, a quick ratio of 0.77 and a current ratio of 1.58.

Plexus (NASDAQ:PLXS) last released its quarterly earnings data on Wednesday, January 28th. The technology company reported $1.78 earnings per share for the quarter, topping analysts’ consensus estimates of $1.77 by $0.01. Plexus had a net margin of 4.28% and a return on equity of 12.55%. The company had revenue of $1.07 billion for the quarter, compared to analysts’ expectations of $1.07 billion. During the same quarter last year, the company earned $1.73 earnings per share. The firm’s revenue for the quarter was up 9.6% on a year-over-year basis. Plexus has set its Q2 2026 guidance at 1.800-1.950 EPS. As a group, equities research analysts forecast that Plexus will post 5.9 EPS for the current fiscal year.

Insider Transactions at Plexus

In other Plexus news, CAO Angelo Michael Ninivaggi, Jr. sold 1,347 shares of the business’s stock in a transaction on Wednesday, November 26th. The shares were sold at an average price of $144.93, for a total transaction of $195,220.71. Following the sale, the chief accounting officer directly owned 21,544 shares in the company, valued at approximately $3,122,371.92. The trade was a 5.88% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CEO Todd P. Kelsey sold 2,000 shares of the business’s stock in a transaction dated Tuesday, November 4th. The stock was sold at an average price of $143.50, for a total transaction of $287,000.00. Following the sale, the chief executive officer directly owned 60,714 shares in the company, valued at approximately $8,712,459. This represents a 3.19% decrease in their position. The SEC filing for this sale provides additional information. Insiders have sold 9,674 shares of company stock valued at $1,382,876 over the last 90 days. Insiders own 1.78% of the company’s stock.

Institutional Trading of Plexus

Institutional investors have recently bought and sold shares of the company. Salomon & Ludwin LLC purchased a new stake in shares of Plexus in the 3rd quarter worth about $30,000. Allworth Financial LP lifted its holdings in shares of Plexus by 70.1% in the third quarter. Allworth Financial LP now owns 250 shares of the technology company’s stock valued at $36,000 after purchasing an additional 103 shares in the last quarter. Huntington National Bank grew its position in shares of Plexus by 41.5% in the second quarter. Huntington National Bank now owns 324 shares of the technology company’s stock valued at $44,000 after purchasing an additional 95 shares during the last quarter. Johnson Financial Group Inc. purchased a new position in shares of Plexus during the 3rd quarter worth approximately $72,000. Finally, Farther Finance Advisors LLC raised its position in shares of Plexus by 114.7% during the 4th quarter. Farther Finance Advisors LLC now owns 511 shares of the technology company’s stock worth $75,000 after purchasing an additional 273 shares during the last quarter. 94.45% of the stock is currently owned by hedge funds and other institutional investors.

Trending Headlines about Plexus

Here are the key news stories impacting Plexus this week:

• Positive Sentiment: Q1 results beat or matched Street expectations: revenue of $1.07B (+10% y/y) and adjusted (non‑GAAP) EPS $1.78; management set Q2 revenue/EPS guidance above consensus and flagged accelerating sequential growth driven by program ramps. Plexus Announces Fiscal First Quarter Financial Results
• Positive Sentiment: High-value program wins and market-share gains: Plexus won 22 new manufacturing programs with $283M of annualized revenue potential (record quarterly Aerospace/Defense wins), supporting management’s view that FY26 revenue growth could meet or exceed the high end of its 9–12% target. Seeking Alpha: Revenue Growth Potential
• Positive Sentiment: Analyst support: Benchmark raised its price target to $195 and reiterated a Buy; Needham/other analysts have also been supportive/upgrading targets after the quarter — analyst action likely amplified buying. Benchmark Boosts Plexus Price Target TipRanks: Needham $206 PT
• Positive Sentiment: Capital return and buybacks: management repurchased $22.4M of shares under the $100M authorization, supporting per-share metrics and investor sentiment. Press Release (buybacks)
• Neutral Sentiment: Analyst views are not unanimous — some outlets characterize opinions as mixed on tech names including Plexus; this tempers uniform bullishness. Globe & Mail: Mixed Analyst Opinions
• Neutral Sentiment: Detailed readouts/transcript available for investors reviewing guidance detail and management commentary on program ramps and end-market demand. Earnings Call Transcript
• Negative Sentiment: Cash and profitability caveats: GAAP diluted EPS declined sequentially (to $1.51) and the quarter produced negative free cash flow (~$50.6M) as working capital and inventory rose to support ramps — short-term cash pressure and inventory build are risks. QuiverQuant: Q1 Results and Cash Flow
• Negative Sentiment: Insider selling and customer concentration: recent disclosures show multiple insider stock sales and top‑10 customers accounted for ~52% of revenue — both are monitoring points for investors. QuiverQuant: Insider Activity & Customer Mix

Plexus Company Profile

Plexus Corp. (NASDAQ: PLXS) is a global provider of electronics manufacturing services (EMS) and precision engineered electronics solutions. Headquartered in Neenah, Wisconsin, the company partners with original equipment manufacturers across industries such as medical, industrial, aerospace and defense, computing, and communications. Plexus offers a full suite of services that span new product introduction, product lifecycle management, supply chain management, printed circuit board assembly, system integration, and aftermarket support.

Founded in 1979, Plexus has grown from a regional electronics assembler into a multinational organization with manufacturing and engineering centers across North America, Europe, and Asia.